BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Osteoporosis clinical trials and catalysts

Active industry-sponsored trials on ClinicalTrials.gov for osteoporosis: 29 (21 sponsors; 2 newly posted in the last 180 days, 0 stopped in the last 180 days; 1 new-entrant sponsors). Momentum score 12.1, rank 58 of 91 on the disease-area ranking. As of 2026-11-18.

Phase distribution: Early Phase 1 0, Phase 1 2, Phase 2 3, Phase 3 3, Phase 4 3, N/A 18.

Most active sponsors, by phase

SponsorActive trialsBy phaseNew (window)Upcoming readouts
Qilu Pharmaceutical Co., Ltd.2P3 202
Luye Pharma Group Ltd.1P3 100
AgNovos Healthcare, LLC4NA 402
Amber Implants B.V.3NA 310
Amgen AMGN2P4 202
Shenzhen Salubris Pharmaceuticals Co., Ltd.2P1 1, P2 100
Angitia Biopharmaceuticals1P2 101
Bespoke Clinical Research1NA 100
Blueprint Medicines Corporation1NA 100
HELP Therapeutics Co., Ltd.1P1 100
Inossia AB1NA 100
Insud Pharma1P4 100
Paola Pisani1NA 100
POROUS GmbH1NA 100
Precision IO Group DTIL1NA 101
Promedius Inc1NA 101
Relation Therapeutics1NA 100
Solarea Bio, Inc1NA 101
Transcenta Therapeutics (Hangzhou) Co., Ltd. new entrant1P2 111
Ufonia1NA 100
Universal Integrated Corp.1NA 100

New-entrant sponsors: Transcenta Therapeutics (Hangzhou) Co., Ltd..

Upcoming trial readouts (next 90 days)

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-12 est.P2Angitia BiopharmaceuticalsNCT06577935 A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)Postmenopausal Osteoporosisactive not recruiting379
2027-01 est.P3Qilu Pharmaceutical Co., Ltd.NCT07062978 A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®Postmenopausal Women With Osteoporosis at High Risk of Fracturerecruiting278

Readouts in the last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-07-30 est.P2Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07579936 A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing RegimensPostmenopausal Women With Osteoporosisrecruiting200

Landscape counts: ClinicalTrials.gov, industry lead sponsors, active statuses, via the free hosted BioCatalystFeed MCP tool condition_landscape (query "osteoporosis"); readouts matched by condition text. Registry counts only; not a forecast.

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.